Cardiometabolic benefits of dual GLP1-RA and SGLT2i therapy in patients with HFpEF, T2DM, obesity, and obstructive sleep apnea: a prospective study

29 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Targeting metabolism in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology